Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with genetically defined diseases.
Stock is 

SEC Filing Details

Document Details

Form
Filing Date
Feb 25, 2021
Document Date
Dec 31, 2020
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Agios Pharmaceuticals, Inc.
Issuer
AGIOS PHARMACEUTICALS INC